SparingVision is the older company (2020 vs 2016); SparingVision is the larger of the two.
Side-by-Side Comparison
| Metric | Capsigen | SparingVision |
|---|---|---|
| Founded | ||
| Founded | 2020 | 2016 older |
| Headquarters | ||
| Headquarters | Vancouver, United States | Paris, France |
| Employees | ||
| Employees | 3 | 49 larger |
| Industry | ||
| Industry | Biotechnology | Biotechnology, Health Care, Life Sciences |
| Funding Stage | ||
| Funding Stage | Seed | Series B |
| Total Funding | ||
| Total Funding | Not tracked yet | $119.50M |
| Funding Rounds | ||
| Funding Rounds | 1 | 3 |
| Services | ||
| Services | Not tracked yet | Development and delivery of innovative genomic medicines for ocular diseases |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients affected by inherited retinal diseases and ocular disorders |
| Taxonomy | ||
| Taxonomy | Gene Therapies, AAV Capsids, Genetic Medicines, Data Science Platforms, RNA Screening, Disease-first Approach, Cell-type Specificity, Drug Development, Precision Medicine, Therapeutic Engineering, Intractable Illness, Biological Engineering, Healthcare Innovation | Genomic Medicines, Ocular Diseases, Inherited Retinal Diseases, Gene-independent Treatments, Research And Development, Retinitis Pigmentosa, Vision-Saving Treatments, Investment, Therapeutic Innovation, Pipeline Development, Rare Disease Treatment, International Collaboration, Sight-saving Treatments, Venture Capital |
| Website | ||
| Website | capsigen.com | sparingvision.com |
About Capsigen
Capsigen is a pioneering biotechnology startup founded in 2020 with the slogan "Driven to Evolve". The company specializes in engineering AAV capsids for gene therapies, with the goal of providing permanent cures for patients suffering from intractable illnesses. Capsigen's approach, which is based...
About SparingVision
SparingVision is a biotechnology startup dedicated to developing genomic medicines for ocular diseases. Founded in 2016, the company aims to revolutionize the treatment of ocular diseases by translating over 20 years of world-leading ophthalmic research into vision-saving therapies. The core focus o...
We will tell you when either one moves
BounceWatch watches Capsigen and SparingVision for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Capsigen and SparingVision — by email.
Frequently Asked Questions
Compare Capsigen with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at Capsigen on 9 Jun 2026, and SparingVision on 7 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.